New Mammography Screening Guidance: Clinical Considerations for Risk-Based Care
-
By
-
May 26, 2026
-
5 min
By
May 26, 2026
Balancing deep biological insight with the realities of development is now central to progress in advanced medicine
May 27, 2026
Merck’s TROP2 ADC delivers a phase III win in endometrial cancer, as new golimumab biosimilars and an oral microbiome therapy move forward
May 26, 2026
Lung cancer resulted in 1.8 million deaths globally in 2022 and remains the leading cause of cancer-related mortality worldwide. Low-dose CT screening has been shown to reduce lung cancer mortality, a...
by Cara Glynn
May 26, 2026